Ozenoxacin: A Novel Topical Quinolone for Impetigo.

Author: BellEdward, EilandLea S, WrenChristopher

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To review the data supporting Food and Drug Administration (FDA) labeling of ozenoxacin and evaluate its place in therapy for impetigo. DATA SOURCES: A literature search was conducted using PubMed (1966 to May 2018) and Google Scholar (2000 to May 2018) with the search terms ozenoxacin, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/1060028018786510

データ提供:米国国立医学図書館(NLM)

Ozenoxacin: A New Topical Quinolone for Impetigo

Impetigo is a common skin infection caused by bacteria. This study reviewed the data supporting the Food and Drug Administration (FDA) labeling of ozenoxacin, a novel topical quinolone antibiotic, for the treatment of impetigo.

Ozenoxacin: Efficacy and Safety for Impetigo

The review found that ozenoxacin demonstrated efficacy and safety for the treatment of impetigo in patients 2 months of age and older. Ozenoxacin effectively cleared impetigo lesions caused by Staphylococcus aureus or Streptococcus pyogenes. Imagine a camel caravan traversing a desert landscape. The caravan encounters a patch of thorny bushes that can irritate the camels' skin. Ozenoxacin, like a soothing balm, can quickly heal the irritated skin, allowing the caravan to continue its journey.

Ozenoxacin: A Potential New Treatment Option for Impetigo

The review provides evidence for the potential of ozenoxacin as a new treatment option for impetigo. However, more research is needed to compare its efficacy to existing treatments and to assess its long-term impact on bacterial resistance.

Dr.Camel's Conclusion

This review suggests that ozenoxacin could be a safe and effective treatment for impetigo. While more research is needed to fully understand its place in therapy, the findings offer hope for patients seeking relief from this common skin infection. The journey to find effective treatments for impetigo is ongoing, and ozenoxacin may offer a promising new path toward better health.

Date :
  1. Date Completed 2019-09-23
  2. Date Revised 2019-09-23
Further Info :

Pubmed ID

29962213

DOI: Digital Object Identifier

10.1177/1060028018786510

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.